Literature DB >> 25480359

Investigation of Heschl's gyrus and planum temporale in patients with schizophrenia and bipolar disorder: a proton magnetic resonance spectroscopy study.

M I Atagün1, E M Şıkoğlu2, S S Can3, G Karakaş-Uğurlu3, S Ulusoy-Kaymak4, A Çayköylü3, O Algın5, M L Phillips6, C M Moore7, D Öngür8.   

Abstract

BACKGROUND: Superior temporal cortices include brain regions dedicated to auditory processing and several lines of evidence suggest structural and functional abnormalities in both schizophrenia and bipolar disorder within this brain region. However, possible glutamatergic dysfunction within this region has not been investigated in adult patients.
METHODS: Thirty patients with schizophrenia (38.67±12.46years of age), 28 euthymic patients with bipolar I disorder (35.32±9.12years of age), and 30 age-, gender- and education-matched healthy controls were enrolled. Proton magnetic resonance spectroscopy data were acquired using a 3.0T Siemens MAGNETOM TIM Trio MR system and single voxel Point REsolved Spectroscopy Sequence (PRESS) in order to quantify brain metabolites within the left and right Heschl's gyrus and planum temporale of superior temporal cortices.
RESULTS: There were significant abnormalities in glutamate (Glu) (F(2,78)=8.52, p<0.0001), N-acetyl aspartate (tNAA) (F(2,81)=5.73, p=0.005), creatine (tCr) (F(2,83)=5.91, p=0.004) and inositol (Ins) (F(2,82)=8.49, p<0.0001) concentrations in the left superior temporal cortex. In general, metabolite levels were lower for bipolar disorder patients when compared to healthy participants. Moreover, patients with bipolar disorder exhibited significantly lower tCr and Ins concentrations when compared to schizophrenia patients. In addition, we have found significant correlations between the superior temporal cortex metabolites and clinical measures.
CONCLUSION: As the left auditory cortices are associated with language and speech, left hemisphere specific abnormalities may have clinical significance. Our findings are suggestive of shared glutamatergic abnormalities in schizophrenia and bipolar disorder.
Copyright © 2013 Elsevier B.V. All rights reserved.

Entities:  

Keywords:  Bipolar disorder; Glutamate; Glutamine; Magnetic resonance spectroscopy; Schizophrenia; Superior temporal cortex

Mesh:

Substances:

Year:  2014        PMID: 25480359      PMCID: PMC4308441          DOI: 10.1016/j.schres.2014.11.012

Source DB:  PubMed          Journal:  Schizophr Res        ISSN: 0920-9964            Impact factor:   4.939


  79 in total

1.  Regarding "Increased prefrontal and hippocampal glutamate concentration in schizophrenia: evidence from a magnetic resonance spectroscopy study".

Authors:  Jean Théberge; J Eric Jensen; Laura M Rowland
Journal:  Biol Psychiatry       Date:  2006-09-01       Impact factor: 13.382

2.  Thalamocortical abnormalities in auditory brainstem response patterns distinguish DSM-IV bipolar disorder type I from schizophrenia.

Authors:  Mia Sköld; Johan Källstrand; Sara Nehlstedt; Annelie Nordin; Sören Nielzén; Jens Holmberg; Rolf Adolfsson
Journal:  J Affect Disord       Date:  2014-08-13       Impact factor: 4.839

3.  Evidence for glutamatergic neuronal dysfunction in the prefrontal cortex in chronic but not in first-episode patients with schizophrenia: a proton magnetic resonance spectroscopy study.

Authors:  Patricia Ohrmann; Ansgar Siegmund; Thomas Suslow; Katharina Spitzberg; Anette Kersting; Volker Arolt; Walter Heindel; Bettina Pfleiderer
Journal:  Schizophr Res       Date:  2005-03-01       Impact factor: 4.939

Review 4.  Proton magnetic resonance spectroscopy and illness stage in schizophrenia--a systematic review and meta-analysis.

Authors:  Stefan Brugger; John M Davis; Stefan Leucht; James M Stone
Journal:  Biol Psychiatry       Date:  2010-12-08       Impact factor: 13.382

5.  Creatine abnormalities in schizophrenia and bipolar disorder.

Authors:  Dost Ongür; Andrew P Prescot; J Eric Jensen; Bruce M Cohen; Perry F Renshaw
Journal:  Psychiatry Res       Date:  2009-02-23       Impact factor: 3.222

Review 6.  Proton magnetic resonance spectroscopy changes after antipsychotic treatment.

Authors:  Agata Szulc; Beata Galinska-Skok; Napoleon Waszkiewicz; Daniel Bibulowicz; Beata Konarzewska; Eugeniusz Tarasow
Journal:  Curr Med Chem       Date:  2013       Impact factor: 4.530

7.  Decrease of theta response in euthymic bipolar patients during an oddball paradigm.

Authors:  M İ Atagün; B Güntekin; A Ozerdem; E Tülay; E Başar
Journal:  Cogn Neurodyn       Date:  2012-12-09       Impact factor: 5.082

8.  Learning potential on the WCST in schizophrenia is related to the neuronal integrity of the anterior cingulate cortex as measured by proton magnetic resonance spectroscopy.

Authors:  Patricia Ohrmann; Harald Kugel; Jochen Bauer; Ansgar Siegmund; Katja Kölkebeck; Thomas Suslow; Karl H Wiedl; Matthias Rothermundt; Volker Arolt; Anya Pedersen
Journal:  Schizophr Res       Date:  2008-09-16       Impact factor: 4.939

9.  Brain metabolic alterations in medication-free patients with bipolar disorder.

Authors:  Stephen R Dager; Seth D Friedman; Aimee Parow; Christina Demopulos; Andrew L Stoll; In Kyoon Lyoo; David L Dunner; Perry F Renshaw
Journal:  Arch Gen Psychiatry       Date:  2004-05

10.  Glutamine and glutamate levels in children and adolescents with bipolar disorder: a 4.0-T proton magnetic resonance spectroscopy study of the anterior cingulate cortex.

Authors:  Constance M Moore; Jean A Frazier; Carol A Glod; Janis L Breeze; Megan Dieterich; Chelsea T Finn; Blaise deB Frederick; Perry F Renshaw
Journal:  J Am Acad Child Adolesc Psychiatry       Date:  2007-04       Impact factor: 8.829

View more
  17 in total

1.  A Neural "Tuning Curve" for Multisensory Experience and Cognitive-Perceptual Schizotypy.

Authors:  Francesca Ferri; Yuliya S Nikolova; Mauro Gianni Perrucci; Marcello Costantini; Antonio Ferretti; Valentina Gatta; Zirui Huang; Richard A E Edden; Qiang Yue; Marco D'Aurora; Etienne Sibille; Liborio Stuppia; Gian Luca Romani; Georg Northoff
Journal:  Schizophr Bull       Date:  2017-07-01       Impact factor: 9.306

2.  Perisylvian GABA levels in schizophrenia and bipolar disorder.

Authors:  Murat İlhan Atagün; Elif Muazzez Şıkoğlu; Çağlar Soykan; Can Serdar Süleyman; Semra Ulusoy-Kaymak; Ali Çayköylü; Oktay Algın; Mary Louise Phillips; Dost Öngür; Constance Mary Moore
Journal:  Neurosci Lett       Date:  2016-11-24       Impact factor: 3.046

3.  Serum phosphatidylinositol as a biomarker for bipolar disorder liability.

Authors:  Emma Em Knowles; Peter J Meikle; Kevin Huynh; Harald Hh Göring; Rene L Olvera; Samuel R Mathias; Ravi Duggirala; Laura Almasy; John Blangero; Joanne E Curran; David C Glahn
Journal:  Bipolar Disord       Date:  2017-02-23       Impact factor: 6.744

4.  Subcomponents of brain T2* relaxation in schizophrenia, bipolar disorder and siblings: A Gradient Echo Plural Contrast Imaging (GEPCI) study.

Authors:  Daniel Mamah; Jie Wen; Jie Luo; Xialing Ulrich; Deanna M Barch; Dmitriy Yablonskiy
Journal:  Schizophr Res       Date:  2015-10-23       Impact factor: 4.939

5.  Neurochemical differences between bipolar disorder type I and II in superior temporal cortices: A proton magnetic resonance spectroscopy study.

Authors:  Murat İlhan Atagün; Elif Muazzez Şıkoğlu; Serdar Süleyman Can; Görkem Karakaş Uğurlu; Semra Ulusoy Kaymak; Ali Çayköylü; Oktay Algın; Mary L Phillips; Constance M Moore; Dost Öngür
Journal:  J Affect Disord       Date:  2018-04-04       Impact factor: 4.839

Review 6.  Glutamatergic and GABAergic metabolite levels in schizophrenia-spectrum disorders: a meta-analysis of 1H-magnetic resonance spectroscopy studies.

Authors:  Tomomi Nakahara; Sakiko Tsugawa; Yoshihiro Noda; Fumihiko Ueno; Shiori Honda; Megumi Kinjo; Hikari Segawa; Nobuaki Hondo; Yukino Mori; Honoka Watanabe; Kazuho Nakahara; Kazunari Yoshida; Masataka Wada; Ryosuke Tarumi; Yusuke Iwata; Eric Plitman; Sho Moriguchi; Camilo de la Fuente-Sandoval; Hiroyuki Uchida; Masaru Mimura; Ariel Graff-Guerrero; Shinichiro Nakajima
Journal:  Mol Psychiatry       Date:  2021-09-28       Impact factor: 15.992

7.  Main Effects of Diagnoses, Brain Regions, and their Interaction Effects for Cerebral Metabolites in Bipolar and Unipolar Depressive Disorders.

Authors:  Hai-Zhu Tan; Hui Li; Chen-Feng Liu; Ji-Tian Guan; Xiao-Bo Guo; Can-Hong Wen; Shao-Min Ou; Yin-Nan Zhang; Jie Zhang; Chong-Tao Xu; Zhi-Wei Shen; Ren-Hua Wu; Xue-Qin Wang
Journal:  Sci Rep       Date:  2016-11-21       Impact factor: 4.379

8.  Increased Glutamate Plus Glutamine in the Right Middle Cingulate in Early Schizophrenia but Not in Bipolar Psychosis: A Whole Brain 1H-MRS Study.

Authors:  Juan R Bustillo; Elizabeth G Mayer; Joel Upston; Thomas Jones; Crystal Garcia; Sulaiman Sheriff; Andrew Maudsley; Mauricio Tohen; Charles Gasparovic; Rhoshel Lenroot
Journal:  Front Psychiatry       Date:  2021-06-07       Impact factor: 5.435

Review 9.  Brain oscillations in bipolar disorder and lithium-induced changes.

Authors:  Murat İlhan Atagün
Journal:  Neuropsychiatr Dis Treat       Date:  2016-03-07       Impact factor: 2.570

10.  Brain structure, function, and neurochemistry in schizophrenia and bipolar disorder-a systematic review of the magnetic resonance neuroimaging literature.

Authors:  Badari Birur; Nina Vanessa Kraguljac; Richard C Shelton; Adrienne Carol Lahti
Journal:  NPJ Schizophr       Date:  2017-04-03
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.